Meeting
2020 ASCO Virtual Scientific Program
Integration of the stem cell biology-based genomic tool, StemPrintER, with clinicopathological parameters for the prediction of distant recurrence in ER+/HER2- breast cancer (BC) patients.
Authors
Salvatore Pece
European Institute of Oncology, Milan, Italy
Salvatore Pece , Patrick Maisonneuve , Davide Disalvatore , Stefano Freddi , Paolo Veronesi , Marco Colleoni , Giuseppe Viale , Pier Paolo Di Fiore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Hormone Receptor-Positive
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1057)
DOI
10.1200/JCO.2020.38.15_suppl.1057
Abstract #
1057
Poster Bd #
142
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Comparison of StemPrintER, a novel biology-based genomic predictor of distant recurrence in breast cancer, with Oncotype DX in the TransATAC cohort.
First Author: Salvatore Pece
Poster
2023 ASCO Breakthrough
Risk factors and predictors of tumor recurrence among breast cancer patients in a tertiary government hospital in the Philippines.
First Author: Omar Paningbatan Maaño
Poster
2023 ASCO Annual Meeting
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
First Author: Augustin Vannier
Poster
2023 ASCO Annual Meeting
SEER analysis of 9-year breast cancer specific mortality (BCSM) in patients (pts) with invasive lobular breast cancer (ILC) assessed by the 21-gene Breast Recurrence Score assay.
First Author: Charles E. Geyer Jr.